IntelGenx Technologies
Overview
Raised: $221,830
Total Commitments ($USD)
Digital Offering
02/16/2024
Not Provided
$750
Equity - Preferred
Series A
RegA+
$10.00
$2,687,310,150
1999
Healthcare & Pharmaceuticals
HealthTech
B2B/B2C
Low
High
Balance Sheet
|
Cash and Cash Equivalents |
$1,904,000 |
|
Investment Securities |
$173,000 |
|
Accounts and Notes Receivable |
$606,000 |
|
Property, Plant and Equipment (PP&E) |
$3,976,000 |
|
Property and Equipment |
$3,976,000 |
| Total Assets |
$8,113,000 |
|
Accounts Payable & Accrued Liabilities |
$3,193,000 |
|
Long Term Debt |
$8,500,000 |
|
Total Liabilities |
$19,019,000 |
|
Total Stockholders' Equity |
$-10,906,000 |
| Total Liabilities and Equity |
$8,113,000 |
Statement of Comprehensive Income Information
|
Total Revenues |
$318,000 |
|
Costs & Expenses Applicable to Rev |
$2,688,000 |
|
Depreciation and Amortization |
$200,000 |
| Net Income |
$-2,759,000 |
|
Earnings Per Share - Basic |
$-0.01 |
|
Earnings Per Share - Diluted |
$-0.01 |
Raise History
| Offering Name | Close Date | Platform | Valuation | Total Raised | Security Type | Status | Reg Type |
|---|---|---|---|---|---|---|---|
| IntelGenx Technologies | 05/31/2024 | Digital Offering | $2,687,310,150 | $221,830 | Equity - Preferred | Not Funded | RegA+ |
No prior online funding rounds.
Upgrade to gain access
-
$12.50 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific
Kingscrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual
Edge
Ratings 
